WHO ICTRP trial
Therapeutic reactivity of Ustekinumab in moderate to severe active stage Crohn's…
JPRN-UMIN000028139 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000028139 |
|---|---|
| Public title | Therapeutic reactivity of Ustekinumab in moderate to severe active stage Crohn's disease |
| Scientific title | Therapeutic reactivity of Ustekinumab in moderate to severe active stage Crohn's disease - Therapeutic reactivity of Ustekinumab in moderate to severe active stage Crohn's disease |
| Primary sponsor | Graduate School of Medical Sciences, Kyushu University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Crohn's disease |
| Interventions | Treatment with Ustekinumab |
| Registration date | Jul 7, 2017 |
| Target size | 50 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: